but serious and life-threatening diseases, including: • Multiple Sclerosis, Idiopathic Pulmonary Fibrosis, & Nasopharyngeal Carcinoma EMI-348 and EBV-AutoimmuneAymphoproliferative disease • These indications offer potential significant add-on upside for EPS-348as well as representing a paradigm-changing therapeutic approach